Urokinase is an enzyme protein isolated from healthy human urine or
obtained from human kidney tissue culture. It consists of two parts with
molecular weights of 33,000 and 54,000 mg of protein, respectively. This product
directly acts on the endogenous fibrinolytic system, and can catalyze the
cleavage of plasminogen into plasmin, which can not only degrade fibrin clots,
but also degrade fibrinogen, coagulation factor V and coagulation in the blood
circulation. Factor VIII, etc., so as to play a thrombolytic effect.
Qingdao Kangyuan Biopharmaceutical Group was established in 1991 and was
recognized as the "hidden champion" of the domestic manufacturing industry in
The group now covers an area of ??more than 1,000 mu. It has two raw
material pharmaceutical factories of Qingdao Kangyuan Pharmaceutical and Qingdao
Jiulong Biopharmaceuticals, two preparation factories of Qingdao Huamaishi
Pharmaceutical and Qingdao Guanlong Biopharmaceuticals, as well as 5 wholly
foreign-owned, A joint-venture pharmaceutical enterprise; owns 37 biological
APIs and 59 formulations, and has formed a complete industrial chain from basic
raw materials to APIs to formulations, from China to the world.
The above is the relevant content summarized by the editor of Kangyuan
Company. If you want to know more, please continue to follow us. We will
regularly update you about Human chorionic gonadotropin, Human Menopausal
Gonadotropin supplier, Urofollitropin price, Urokinase manufacturer, Hormone API
Manufacturer Related content, I hope to help you.